Vor bio demonstrates potential of base and sequential multiplex editing of hematopoietic stem cells for next-generation aml treatment

-multiplex deletion of myeloid antigens cd33 and cll-1 or cd33 and cd123 in human hematopoietic stem cells resulted in long-term engraftment and persistence of editing

VOR Ratings Summary

VOR Quant Ranking